Flapless procedure corrects presbyopia

Article

Intrastromal treatment optimal for patients with mild hyperopia, has strict indications

Flapless intrastromal correction of presbyopia (IntraCor) with a femtosecond laser (Femtec 520F, Technolas Perfect Vision) provides good presbyopic correction with slight decreases in distance vision. However, the indications for the monovision procedure are strict and it provides the optimal results in patients with mild hyperopia.

Dr Erik L. Mertens, FEBOphth, presented his findings at the annual meeting of the American Society of Cataract and Refractive Surgery.

The technique

The femtosecond laser is an 80KHz device. When performing the presbyopia treatment, 40 KHz is used. Using this procedure, five microscopic, concentric ring patterns are created in the stroma that alter the corneal curvature and correct presbyopia. The creation of three and six rings is being investigated but is not yet approved. Currently, one eye is treated at a time, and the nondominant eye is treated first, explained Dr Mertens.

Immediately postoperatively, air bubbles are visible in the cornea and almost resolve by 2 hours after the procedure; by 1 month postoperatively the effects of the procedure are barely visible. Dr Mertens showed on optical coherence tomography images that there is a safety zone between Descemet's membrane and the area treated with the procedure.

Probably the most important aspect of this procedure is centration. Topographic evaluation shows central steepening that, according to Dr Mertens, works very well, when the treatment is well centred.

"With this procedure, centration is extremely important," he said.

In Dr Merten's hands, this procedure is best performed in patients who have refractive errors of +0.5 to +1.25 D. When he initially treated patients who had plano presbyopia, the patients were unhappy postoperatively with the slight myopic shift and resultant mild loss of their distance visual acuity. After the surgery, patients who had mild hyperopia had some glare and halos, and some patients developed dry eye, but these may not be related to the procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.